New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2012
11:34 EDTBRLIBio-Reference Labs bought all Meridian common stock for $1.9M
In a regulatory filing the company announced that on December 21, Bio-Reference Laboratories entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida, pursuant to which the company purchased all issued and outstanding common stock of Meridian for approximately $1,850,000, of which $250,000 is deferred for one year. $1,600,000 was paid in cash.
News For BRLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
11:12 EDTBRLIOPKO granted early termination of waiting period for Bio-Reference acquisition
OPKO Health (OPK) and Bio-Reference Laboratories (BRLI) announced that early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has been granted, effective July 1, for OPKO's planned acquisition of Bio-Reference. Expiration of the waiting period under the HSR Act satisfies one of the conditions necessary for the consummation of the merger. The transaction remains subject to other closing conditions, including the approval of Bio-Reference shareholders. The parties continue to expect that this transaction will close during the second half of 2015.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use